Grepafloxacin hydrochloride was an oral broad-spectrum fluoroquinolone
antibacterial agent used to treat bacterial infections. Grepafloxacin was
Jun 13, 2005 ... Grepafloxacin was withdrawn in the United States due to its side effect of
lengthening the QT interval on the electrocardiogram, leading to ...
Dec 8, 2004 ... Learn about Raxar (Grepafloxacin) may treat, uses, dosage, side effects, drug
interactions, warnings, patient labeling, reviews, and related ...
Learn about indications, dosage and how it is supplied for the drug Raxar (
Glaxo Wellcome has announced that it is voluntarily withdrawing the oral
fluoroquinolone antibiotic, grepafloxacin, with immediate effect. Since marketing
Raxar (grepafloxacin): Treatment for chronic bronchitis. New approved drug
details including side effects, uses and general information.
The safety profile of grepafloxacin has been characterized in a number of
preclinical and clinical studies. Preclinical investigations have shown that its ...
Withdrawal of Product: RAXAR( (grepafloxacin HCl) 600 mg Tablets, 400 mg
Tablets, and 200 mg Tablets. Glaxo Wellcome has voluntarily withdrawn all ...
Grepafloxacin is an asymmetric fluoroquinolone derivative which possesses high
tissue penetrability as well as strong, broad-spectrum antimicrobial activities.
Dec 29, 2014 ... A comparison of the structure of ciprofloxacin and grepafloxacin shows that the
two compounds are similar, with two exceptions: grepafloxacin ...